NAICS Code 621111-17 - Pulmonary & Respiratory Diseases

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 387
Contact Emails: 1,267
Company Websites: 362
Phone Numbers: 381
Business Addresses: 387
Companies with Email: 141
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead

Business List Pricing Tiers

Quantity of Records Price Per Record Estimated Total (Max in Tier)
0 - 1,000 $0.25 Up to $250
1,001 - 2,500 $0.20 Up to $500
2,501 - 10,000 $0.15 Up to $1,500
10,001 - 25,000 $0.12 Up to $3,000
25,001 - 50,000 $0.09 Up to $4,500
50,000+ Contact Us for a Custom Quote

What's Included in Every Standard Data Package

  • Company Name
  • Contact Name (where available)
  • Job Title (where available)
  • Full Business & Mailing Address
  • Business Phone Number
  • Industry Codes (Primary and Secondary SIC & NAICS Codes)
  • Sales Volume
  • Employee Count
  • Website (where available)
  • Years in Business
  • Location Type (HQ, Branch, Subsidiary)
  • Modeled Credit Rating
  • Public / Private Status
  • Latitude / Longitude
  • ...and more (Inquire)

Boost Your Data with Verified Email Leads

Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!

Ideal for: Direct Mailing Email Campaigns Calling Market ResearchFree Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 621111 - Offices of Physicians (except Mental Health Specialists) - 892,121 companies, 2,360,298 emails.

NAICS Code 621111-17 Description (8-Digit)

The Pulmonary & Respiratory Diseases industry involves the diagnosis, treatment, and management of conditions affecting the respiratory system. This includes diseases such as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, lung cancer, and tuberculosis. Professionals in this industry work to improve the respiratory health of patients through a range of medical interventions, including medication, oxygen therapy, and pulmonary rehabilitation.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 621111 page

Tools

Tools commonly used in the Pulmonary & Respiratory Diseases industry for day-to-day tasks and operations.

  • Spirometer
  • Peak flow meter
  • Oxygen concentrator
  • Nebulizer
  • Ventilator
  • Bronchoscope
  • Pulse oximeter
  • Chest X-ray machine
  • CT scanner
  • MRI machine

Industry Examples of Pulmonary & Respiratory Diseases

Common products and services typical of NAICS Code 621111-17, illustrating the main business activities and contributions to the market.

  • Asthma management
  • COPD treatment
  • Pneumonia diagnosis
  • Lung cancer screening
  • Tuberculosis management
  • Pulmonary rehabilitation
  • Sleep apnea treatment
  • Cystic fibrosis management
  • Pulmonary fibrosis diagnosis
  • Bronchiectasis treatment

History

A concise historical narrative of NAICS Code 621111-17 covering global milestones and recent developments within the United States.

  • The history of the Pulmonary & Respiratory Diseases industry dates back to ancient times, where the Greeks and Romans used various herbs and plants to treat respiratory ailments. In the 19th century, the discovery of anesthesia and the invention of the stethoscope revolutionized the diagnosis and treatment of respiratory diseases. The 20th century saw significant advancements in the industry, including the development of antibiotics, vaccines, and inhalers. In recent years, the industry has seen a surge in research and development, with new treatments and therapies being developed to combat respiratory diseases such as asthma, COPD, and lung cancer. In the United States, the industry has been heavily impacted by the COVID-19 pandemic, with a significant increase in demand for respiratory equipment and treatments.